Clinical Trial Update: Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab, cisplatin, fluorouracil, and radiation therapy for anal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• FLUOROURACIL (Fluorouracil)
• Radiation therapy

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Anal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-29